ONIT Dry Eye Research Study By JoAnn DeRousse, COT on April 22, 2012

DRY EYE RESEARCH STUDY

Mulqueeny Eye Centers is conducting a research study for people with dry eye disease. The purpose of this research study is to better understand the role that Omega 3 supplements play in regulating tear osmolarity (quality of tear film) in patients with established findings consistent with dry eye.

Secondly, this study will attempt to discover if any other diagnostic testing is affected in a positive and predictive manner by adding an Omega 3 supplement, namely EZ Tears®, as a therapeutic agent.

To be eligible for this research study, you must

Be at least male/female age 18 -79 years old
Have dry eye disease and/or dry eye symptoms
Have moderate to severe eye surface discomfort and symptoms of unhealthy tears
Be willing to attend 4 study visits over a period of 8 weeks
NOT have significant eyelid deformity or eyelid movement disorder
NOT have history of previous ocular disease requiring current topical eye therapy
NOT have a history of herpes keratitis, varizella zoster, allergic conjunctivitis or other active corneal or conjunctival infection of the eye and/or ocular scarring
NOT use or plan to use cyclosporine, any topical eyedrops including glaucoma medications, oral tetracyclines, oral nutraceuticals such as flax, fish, black currant seed oils, or any other Omega 3 supplements within 3 weeks of baseline visit or during the course of the study other than what is provided by the Study Site.
NOT have had cataract surgery, LASIK, LASEK, or PRK procedure within the past 12 months
NOT have had punctal cauterization or current punctal plug placement within 30 days of baseline visit
NOT taking chronic systemic medications known to affect tear production including antihistamines, antidepressants, diuretics, corticosteroids, etc. within 30 days of baseline visit